Latest On Ambu A/S (AMBBY):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-08 05:42 EST | News | Ambu A/S (AMBFF) Q2 2023 Earnings Call Transcript | N/A |  |
| 2023-05-08 05:42 EST | News | Ambu A/S 2023 Q2 - Results - Earnings Call Presentation | N/A | |
| 2023-02-07 14:18 EST | News | Ambu A/S 2023 Q1 - Results - Earnings Call Presentation | N/A | |
| 2023-02-07 14:18 EST | News | Ambu A/S (AMBFF) Q1 2023 Earnings Call Transcript | N/A | |
| 2022-11-16 05:30 EST | News | Ambu A/S (AMBFF) Q4 2022 Earnings Call Transcript | N/A | |
| 2022-11-15 12:34 EST | News | Ambu A/S 2022 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-08-25 22:43 EST | News | Ambu A/S (AMBFF) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-02-09 05:05 EST | News | Ambu A/S (AMBFF) CEO Juan Jose Gonzalez on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-02-09 05:05 EST | News | Ambu A/S 2022 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-01-24 14:35 EST | News | Ambu (AMBBY) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference | N/A | |
| 2021-12-15 05:05 EST | Dividend | A dividend of $0.05 has been announced on Nov 9, 2021. It will be paid Dec 31, 2021 with an ex-dividend date of Dec 15, 2021. | Neutral | |
| 2021-11-13 09:03 EST | News | Ambu A/S (AMBFF) CEO Juan Jose Gonzalez on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-11 18:24 EST | News | Ambu A/S 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2021-11-09 23:12 EST | News | Ambu A/S reports Q4 results | N/A | |
| 2021-08-18 01:56 EST | News | Ambu A/S (AMBFF) CEO Juan Jose Gonzalez on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-01-29 09:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-10 05:05 EST | Dividend | A dividend of $0.05 has been announced on Nov 12, 2020. It will be paid Dec 29, 2020 with an ex-dividend date of Dec 10, 2020. | Neutral | |
| 2020-11-26 23:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-13 14:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-12 12:46 EST | News | Ambu A/S 2020 Q4 - Results - Earnings Call Presentation | N/A | |
| 2020-11-12 12:45 EST | News | Ambu A/S (AMBFF) CEO Juan-Jose Gonzalez on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-08 02:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 15:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 07:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-31 07:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-28 14:18 EST | News | Ambu A/S 2020 Q3 - Results - Earnings Call Presentation | N/A | |
| 2020-08-28 14:18 EST | News | Ambu A/S (AMBFF) CEO Juan-Jose Gonzalez on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-08-28 10:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 11:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 15:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 19:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 07:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 23:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 17:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 15:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 20:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 11:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 19:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 02:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 15:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 07:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 07:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 03:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-12 09:32 EST | News | Ambu A/S (AMBFF) CEO Juan-Jose Gonzalez on Q1 2020 Results - Earnings Call Transcript | N/A | |
| 2020-05-06 08:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 07:01 EST | News | Ambu A/S 2020 Q2 - Results - Earnings Call Presentation | N/A | |
| 2020-05-06 03:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-02 22:39 EST | Financials | Company financials have been released. | Neutral | |
About Ambu A/S (AMBBY):
Ambu A/S develops, manufactures, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors, as well as related airway management products comprising video laryngoscopes, double and single lumen tubes, and endobronchial blockers; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers resuscitators, extrication collars, head immobilizers, CPR breathing barriers, suction pumps, video laryngoscopes, and training manikins. It serves hospitals, rescue services, clinics, etc. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.
General
- Name Ambu A/S
- Symbol AMBBY
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- Full Time Employees 4,000
- Last Split Factor1:1
- Last Split Date2018-01-24
- Fiscal Year EndSeptember
- Web URLhttp://www.ambu.com
View More
Valuation
- Trailing PE 205.73
- Price/Sales (Trailing 12 Mt.) 17.97
- Price/Book (Most Recent Quarter) 29.59
- Enterprise Value Revenue 2.98
- Enterprise Value EBITDA 18.65
View More
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin 8%
- Return on Assets 6%
- Return on Equity 13%
- Earnings Per Share $0.21
- Revenue Per Share $0
- Gross Profit 2.21 billion
- Quarterly Earnings Growth 33.3%
View More
Highlights
- Market Capitalization 11.04 billion
- Book Value Per Share $1.21
View More
Share Statistics
- Shares Outstanding 257.39 million
- Shares Float 164.84 million
- % Held by Insiders <1%
View More
Technicals
- Beta 0.24
- 52 Week High $52.99
- 52 Week Low $23.42
- 50 Day Moving Average 47.77
- 200 Day Moving Average 45.79
View More
Dividends
- Forward Annual Dividend Rate $0.05
- Forward Annual Dividend Yield 0.11%
- Payout Ratio 27%
- Dividend Date 2020-12-29
- ExDividend Date 2020-12-10
- Dividend Per Share $0.06
- Dividend Yield 0%
View More
Ambu A/S (AMBBY) Dividend Calendar:
AMBBY's last dividend payment was made to shareholders on December 29, 2020.
Ambu A/S pays out 27% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Ambu A/S (AMBBY) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2020-12-31 | $1.01 billion | $0.06 | ||
| 2020-09-30 | 2020-12-31 | $N/A | $0.06 | ||
| 2020-06-30 | 2020-09-30 | $N/A | $0.00 | ||
| 2020-03-31 | 2020-06-30 | $N/A | $0.06 | ||
| 2019-12-31 | 2020-03-31 | $760 million | $0.06 | ||
| 2019-09-30 | 2019-12-31 | $606 million | $0.03 | ||
| 2019-06-30 | 2019-09-30 | $773 million | -$0.06 | ||
| 2019-03-31 | 2019-06-30 | $785 million | $0.13 | ||
| 2018-12-31 | 2019-03-31 | $656 million | $0.08 | ||
| 2018-09-30 | 2018-12-31 | $729 million | $0.04 | ||
| 2018-06-30 | 2018-09-30 | $673 million | $0.07 | ||
| 2018-03-31 | 2018-06-30 | $651 million | $0.07 | ||
| 2017-12-31 | 2018-03-31 | $553 million | $0.06 | ||
| 2017-09-30 | 2017-12-31 | $629 million | $0.02 | ||
| 2017-06-30 | 2017-09-30 | $601 million | $0.06 | $0.00 | |
| 2017-03-31 | 2017-06-30 | $0.05 | $0.00 | ||
| 2016-12-31 | 2017-03-31 | $0.05 | $0.00 | ||
| 2016-09-30 | 2016-12-31 | $0.03 | $0.00 | ||
| 2016-06-30 | 2016-09-30 | $0.06 | $0.00 | ||
| 2016-03-31 | 2016-06-30 | $0.05 | $0.00 | ||
| 2015-12-31 | 2016-03-31 | $0.03 | $0.00 | ||
| 2015-09-30 | 2015-12-31 | $0.02 | $0.00 | ||
| 2015-06-30 | 2015-09-30 | $0.04 | $0.00 | ||
| 2015-03-31 | 2015-06-30 | $0.01 | $0.00 | ||
| 2014-12-31 | 2015-03-31 | $0.03 | $0.00 | ||
| 2014-09-30 | 2014-12-31 | $0.01 | $0.00 | ||
| 2014-06-30 | 2014-09-30 | $0.06 | $0.00 | ||
| 2014-03-31 | 2014-06-30 | $0.03 | $0.00 | ||
| 2013-12-31 | 2014-03-31 | $0.02 | $0.00 | ||
| 2013-09-30 | 2013-12-31 | $0.00 | $0.00 | ||
| 2013-06-30 | 2013-09-30 | $0.02 | $0.00 | ||
| 2013-03-31 | 2013-06-30 | $0.00 | $0.00 | ||
| 2012-12-31 | 2013-03-31 | $0.00 | $0.00 | ||
| 2012-09-30 | 2012-12-31 | $0.01 | $0.00 | ||
| 2012-06-30 | 2012-09-30 | $0.03 | $0.00 | ||
| 2012-03-31 | 2012-06-30 | $0.02 | $0.00 | ||
| 2011-12-31 | 2012-03-31 | $0.02 | $0.00 | ||
| 2011-09-30 | 2011-12-31 | $0.01 | $0.00 | ||
| 2011-06-30 | 2011-09-30 | $0.02 | $0.00 | ||
| 2011-03-31 | 2011-06-30 | $0.02 | $0.00 | ||
| 2010-12-31 | 2011-03-31 | $0.00 | $0.00 | ||
| 2010-09-30 | 2010-12-31 | $0.01 | $0.00 |
Ambu A/S (AMBBY) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Apr 30 2020 | Mar 31 2020 |
|---|---|---|---|---|---|
| Research Development | 47 million | N/A | N/A | 41 million | N/A |
| Income Before Tax | 118 million | N/A | N/A | 123 million | N/A |
| Selling General Administrative | 467 million | N/A | N/A | 416 million | N/A |
| Gross Profit | 662 million | N/A | N/A | 613 million | N/A |
| Ebit | 176 million | N/A | N/A | 172 million | N/A |
| Operating Income | 148 million | N/A | N/A | 156 million | N/A |
| Income Tax Expense | 27 million | 2 million | 31 million | 31 million | 34 million |
| Total Revenue | 1.01 billion | N/A | N/A | 947 million | N/A |
| Cost of Revenue | 351 million | N/A | N/A | 334 million | N/A |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | N/A |
| Net Income From Continuing Operations | 91 million | N/A | N/A | 92 million | N/A |
| Net Income Applicable to Common Shares | 91 million | 3 million | 92 million | 92 million | 104 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Apr 30 2020 | Mar 31 2020 | Jan 31 2020 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | N/A |
| Change to Liabilities | 72 million | 195 million | 123 million | 160 million | -35 million |
| Total Cash Flow from Investing Activities | -122 million | -129 million | -129 million | -99 million | -99 million |
| Net Borrowings | 42 million | -159 million | -159 million | -4 million | -4 million |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Operating Activities | -203 million | -196 million | N/A | -332 million | N/A |
| Change in Cash | N/A | N/A | N/A | N/A | N/A |
| Total Cash from Operating Activities | 81 million | 314 million | 314 million | 10 million | 10 million |
| Depreciation | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | -19 million | N/A |
| Change to Net Income | 199 million | 158 million | 44 million | 48 million | -24 million |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Apr 30 2020 | Mar 31 2020 |
|---|---|---|---|---|---|
| Total Liabailities | 2.65 billion | N/A | N/A | N/A | N/A |
| Total Stockholder Equity | 2.39 billion | N/A | N/A | N/A | N/A |
| Other Current Liabilities | 443 million | 731 million | N/A | 2.41 billion | N/A |
| Total Assets | 5.04 billion | N/A | N/A | N/A | N/A |
| Common Stock | 126 million | 126 million | 126 million | 427 million | 126 million |
| Other Current Assets | N/A | N/A | N/A | 126 million | N/A |
| Retained Earnings | 2.23 billion | N/A | N/A | 2.17 billion | N/A |
| Other Liabilities | 109 million | 113 million | 110 million | 110 million | 235 million |
| Other Assets | 92 million | 90 million | 123 million | 224 million | 186 million |
| Cash | 173 million | N/A | N/A | 80 million | N/A |
| Total Current Liabilities | 736 million | 1.04 billion | N/A | 1.07 billion | N/A |
| Other Stockholder Equity | 2.27 billion | 2.25 billion | 2.28 billion | 110 million | 2.17 billion |
| Property, Plant & Equipment | 668 million | 664 million | 619 million | 518 million | 519 million |
| Total Current Assets | 1.32 billion | 1.24 billion | N/A | 1.23 billion | N/A |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | -565 million | -563 million | -496 million | -496 million | -574 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | 1.67 billion | N/A | N/A | 1.18 billion | N/A |
| Inventory | 551 million | 515 million | N/A | 471 million | N/A |
| Accounts Payable | 216 million | 259 million | N/A | 250 million | N/A |
Ambu A/S (AMBBY) Chart:
Ambu A/S (AMBBY) News:
Below you will find a list of latest news for Ambu A/S (AMBBY) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Ambu A/S (AMBBY) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Ambu A/S (AMBBY) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|